Literature DB >> 15804443

Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations.

Yoshifumi Sonobe1, Izumi Yawata, Jun Kawanokuchi, Hideyuki Takeuchi, Tetsuya Mizuno, Akio Suzumura.   

Abstract

Production of IL-27 and other IL-12 family cytokines by murine microglia were examined using RT-PCR, real-time RT-PCR and Western blot analysis. We show for the first time that murine microglia produce IL-27 in response to lipopolysaccharide (LPS) and/or interferon-gamma. Primary microglia, but not their cell lines, also induce IL-12 and IL-23 upon above stimulation. Therefore, microglia may play a critical role initiating Th1 responses via producing IL-12 family cytokines in the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804443     DOI: 10.1016/j.brainres.2005.01.100

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

1.  The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses.

Authors:  Shaun A Summers; Richard K S Phoon; Joshua D Ooi; Stephen R Holdsworth; A Richard Kitching
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 2.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

3.  The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Malak G Kolta; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2017-09-20       Impact factor: 3.478

Review 4.  Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.

Authors:  Caroline Pot; Lionel Apetoh; Amit Awasthi; Vijay K Kuchroo
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

5.  Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10.

Authors:  Yun Sang Lee; Ahjoku Amadi-Obi; Cheng-Rong Yu; Charles E Egwuagu
Journal:  Immunology       Date:  2011-02-07       Impact factor: 7.397

6.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

7.  The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.

Authors:  Beichu Guo; Elmer Y Chang; Genhong Cheng
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

8.  Increased beta(2)-adrenergic receptor activity by thyroid hormone possibly leads to differentiation and maturation of astrocytes in culture.

Authors:  Mausam Ghosh; Sumantra Das
Journal:  Cell Mol Neurobiol       Date:  2007-09-08       Impact factor: 5.046

9.  Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.

Authors:  Katherine S Held; William G Glass; Yevgeniya I Orlovsky; Kimberly A Shamberger; Ted D Petley; Patrick J Branigan; Jill M Carton; Heena S Beck; Mark R Cunningham; Jacqueline M Benson; Thomas E Lane
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

10.  Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.

Authors:  J F Yang; H Q Tao; Y M Liu; X X Zhan; Y Liu; X Y Wang; J H Wang; L L Mu; L L Yang; Z M Gao; Q F Kong; G Y Wang; J H Han; B Sun; H L Li
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.